As the post-pandemic world of work continues to evolve, so do recruiters’ strategies and tools for finding and engaging top talent. In 2023, we are seeing these seven trends:1. Employer branding is becoming an increasingly important factor in the recruitment…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY 4 Die after Taking SGLT-2 Inhibitors, Causality under Scrutiny
October 15, 2014
-
BUSINESS Parexel CEO Hails Rise of Partnership-Based Outsourcing in Japan
October 14, 2014
-
ACADEMIA St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
October 10, 2014
-
BUSINESS GSK to Market Authorized Generics through Aspen Japan Unit
October 10, 2014
-
REGULATORY MOF Panel to Pitch Reference Pricing for Long-Listed Drugs, Price Cut in FY2015
October 9, 2014
-
BUSINESS Shire Japan Takes Aim at $500 Million Sales in 10 Years
October 8, 2014
-
BUSINESS Chugai, Roche Chiefs Were in Talks on Recent Deal Change from 2 Years Ago
October 7, 2014
-
BUSINESS JCR Pharmaceuticals Hopes to Make Japan’s First Cell Product into New Profit Pillar
October 6, 2014
-
ORGANIZATION JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
-
BUSINESS MTPC Charges Ahead with Research Lab Overhaul to Buttress Drug Discovery
October 2, 2014
-
BUSINESS Novartis Pharma Notifies PMDA of Additional 1,299 Unreported Serious ADRs
October 2, 2014
-
BUSINESS Kissei to Spice Up Current Portfolio in Next 3 Years, Launch New Drugs Later
October 1, 2014
-
BUSINESS e-Detailing Powerhouse M3 to Establish New Firm Dedicated to CSO Biz
September 30, 2014
-
BUSINESS Avigan Administered to Ebola-Infected French Woman: Fujifilm
September 29, 2014
-
ORGANIZATION JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
September 26, 2014
-
BUSINESS Takeda to Invest 2.5 Billion Yen in US Firm for New Drug Development
September 26, 2014
-
BUSINESS AZ Managed to Speed Up Pilot R&D Projects under New Structure: President
September 25, 2014
-
TRENDS Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
September 24, 2014
-
BUSINESS Mediceo Sets to Increase Qualified Reps to 2,000, Enter Contract PMS Biz within 3 Years
September 22, 2014
-
REGULATORY MHLW Guidelines to Call for Thorough Internal Communications at Pharmas after Novartis’ Delayed ADR Reporting
September 19, 2014
ページ
Novo Nordisk’s weight-loss medication Wegovy (semaglutide) was approved in Japan in March. While it skipped the May round of reimbursement listing, physicians eagerly await the arrival of what would be the first new obesity drug in three decades. Other companies…
Japan’s health ministry on April 27 presented an outline of a report to be compiled next month by its key…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…